JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M211420200 on January 7, 2003

J. Biol. Chem., Vol. 278, Issue 14, 12157-12166, April 4, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
278/14/12157    most recent
M211420200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Myette, J. R.
Right arrow Articles by Sasisekharan, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Myette, J. R.
Right arrow Articles by Sasisekharan, R.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

The Heparin/Heparan Sulfate 2-O-Sulfatase from Flavobacterium heparinum
MOLECULAR CLONING, RECOMBINANT EXPRESSION, AND BIOCHEMICAL CHARACTERIZATION*

James R. MyetteDagger §, Zachary ShriverDagger , Chandra Claycamp||, Maitland W. McLean**, Ganesh VenkataramanDagger Dagger , and Ram SasisekharanDagger §§

From the Dagger  Division of Biological Engineering, || Department of Biology, and Dagger Dagger  Division of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139 and ** Grampian Enzymes, Ltd., Nisthouse Harray, Orkney KW17 2LQ, United Kingdom

Heparan sulfate glycosaminoglycans are structurally complex polysaccharides critically engaged in a wide range of cell and tissue functions. Any structure-based approach to study their respective biological functions is facilitated by the use of select heparan sulfate glycosaminoglycan-degrading enzymes with unique substrate specificities. We recently reported of one such enzyme, the Delta 4,5-glycuronidase cloned from Flavobacterium heparinum and recombinantly expressed in Escherichia coli (Myette, J. R., Shriver, Z., Kiziltepe, T., McLean, M. W., Venkataraman, G., and Sasisekharan, R. (2002) Biochemistry 41, 7424-7434). In this study, we likewise report the molecular cloning of the 2-O-sulfatase from the same bacterium and its recombinant expression as a soluble, highly active enzyme. At the protein level, the flavobacterial 2-O-sulfatase possesses considerable sequence homology to other members of a large sulfatase family, especially within its amino terminus, where the highly conserved sulfatase domain is located. Within this domain, we have identified by sequence homology the critical active site cysteine predicted to be chemically modified as a formylglycine in vivo. We also present a characterization of the biochemical properties of the enzyme as it relates to optimal in vitro reaction conditions and a kinetic description of its substrate specificity. In particular, we demonstrate that in addition to the fact that the enzyme exclusively hydrolyzes the sulfate at the 2-O-position of the uronic acid, it also exhibits a kinetic preference for highly sulfated glucosamines within each disaccharide unit, especially those possessing a 6-O-sulfate. The sulfatase also displays a clear kinetic preference for disaccharides with beta 1right-arrow4 linkages but is able, nevertheless, to hydrolyze unsaturated, 2-O-sulfated chondroitin disaccharides. Finally, we describe the substrate-product relationship of the 2-O-sulfatase to the Delta 4,5-glycuronidase and the analytical value of using both of these enzymes in tandem for elucidating heparin/heparan sulfate composition.


* This work was supported by National Institutes of Health (NIH) Grants GM 57073 and CA90940.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ Recipient of NIH/MIT Toxicology Training Grant 5T32GM08334.

Recipient of Merck/MIT fellowship.

§§ To whom correspondence should be addressed: Division of Biological Engineering, Massachusetts Institute of Technology, 77 Massachusetts Ave., Cambridge, MA 02139. Tel.: 617-258-9494; Fax: 617-258-9409.


Copyright © 2003 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
O. Berteau, A. Guillot, A. Benjdia, and S. Rabot
A New Type of Bacterial Sulfatase Reveals a Novel Maturation Pathway in Prokaryotes
J. Biol. Chem., August 11, 2006; 281(32): 22464 - 22470.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Raman, J. R. Myette, Z. Shriver, K. Pojasek, G. Venkataraman, and R. Sasisekharan
The Heparin/Heparan Sulfate 2-O-Sulfatase from Flavobacterium heparinum. A STRUCTURAL AND BIOCHEMICAL STUDY OF THE ENZYME ACTIVE SITE AND SACCHARIDE SUBSTRATE SPECIFICITY
J. Biol. Chem., March 28, 2003; 278(14): 12167 - 12174.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.